Intuitive Surgical, Inc.
HealthcareNASDAQ:ISRG · NASDAQ Global Select
-$4.81 today
Vol 0.84M · Avg 2.56M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $2.9B +23.1% | $2.3B +28.6% | $1.8B +35.2% | $1.3B -22.2% | $1.7B | $487.6M | $476.4M | $465.2M |
| Depreciation & Amortization | $677.1M +46.6% | $462.0M +6.2% | $435.2M +19.0% | $365.8M +17.9% | $310.2M | $374.2M | $1.2B | $631.8M |
| Deferred Income Tax | $19.1M +114.1% | -$135.3M +51.8% | -$280.8M -51.5% | -$185.3M -196.0% | -$62.6M | $1.4B | -$1.5B | $304.2M |
| Stock-Based Compensation | $788.2M +16.5% | $676.8M +13.1% | $598.2M +16.6% | $513.2M +14.2% | $449.2M | $489.0M | $354.6M | -$1.6B |
| Change in Working Capital | -$1.3B -38.4% | -$919.3M -18.2% | -$777.6M -25.6% | -$619.1M -68.2% | -$368.1M | $350.4M | -$1.6B | $1.5B |
| Accounts Receivables | -$301.7M -214.6% | -$95.9M +48.5% | -$186.3M -16.9% | -$159.3M -11.9% | -$142.3M | $592.6M | $1.3B | $626.2M |
| Inventory | -$1.1B -28.1% | -$830.0M -16.5% | -$712.5M -30.4% | -$546.6M -113.5% | -$256.0M | $1.0B | $1.2B | $1.1B |
| Accounts Payables | $57.9M +14575.0% | -$400.0K -101.0% | $41.7M +95.8% | $21.3M -40.8% | $36.0M | $948.2M | -$1.5B | $433.0M |
| Other Working Capital | $34.9M +398.6% | $7.0M -91.2% | $79.5M +21.4% | $65.5M +1229.3% | -$5.8M | $567.4M | $1.3B | $601.0M |
| Other Non-Cash Items | -$58.2M -768.7% | -$6.7M -131.2% | $21.5M -70.1% | $71.8M +120.2% | $32.6M | $1.4B | -$1.5B | $300.0M |
| Operating Cash Flow | $3.0B +25.5% | $2.4B +33.1% | $1.8B +21.7% | $1.5B -28.6% | $2.1B | $7.2B | $8.9B | $10.5B |
| Capital Expenditures | -$539.8M +51.4% | -$1.1B -4.4% | -$1.1B -99.9% | -$532.4M -50.6% | -$353.5M | $664.0M | $1.4B | $697.6M |
| Acquisitions (Net) | -$13.9M -1290.0% | -$1.0M +88.8% | -$8.9M +30.5% | -$12.8M -47.1% | -$8.7M | $937.0M | $1.1B | $1.3B |
| Purchases of Investments | -$1.2B +76.3% | -$5.1B -132.8% | -$2.2B -57.7% | -$1.4B +78.3% | -$6.5B | $444.2M | $1.4B | $1.3B |
| Sales of Investments | $2.4B -18.2% | $3.0B +2.0% | $2.9B -11.9% | $3.3B -23.8% | $4.4B | $822.2M | $318.2M | -$1.5B |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $616.4M | $370.0M | $1.2B |
| Investing Cash Flow | $665.8M +120.3% | -$3.3B -808.9% | -$360.1M -126.3% | $1.4B +155.7% | -$2.5B | $4.8B | $6.4B | $5.1B |
| Debt Repayment | $0 | $0 | $0 | $0 | $0 | $680.8M | $759.2M | $1.1B |
| Common Stock Issued | $350.3M -18.4% | $429.4M | $0 | $0 -100.0% | $276.5M | $778.8M | $946.8M | $812.4M |
| Common Stock Repurchased | -$2.3B | $0 +100.0% | -$416.3M +84.0% | -$2.6B | $0 | $351.8M | -$1.6B | $1.5B |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $535.2M | $613.6M | $692.0M |
| Other Financing Activities | -$419.1M -50.5% | -$278.5M -316.4% | $128.7M +164.8% | -$198.7M +14.9% | -$233.5M | -$1.6B | $1.3B | $1.1B |
| Financing Cash Flow | -$2.4B -1666.7% | $150.9M +152.5% | -$287.6M +88.8% | -$2.6B -6082.1% | $43.0M | $12.2B | $13.9B | -$15.5B |
| Effect of Forex Changes | $12.8M +1700.0% | -$800.0K -124.2% | $3.3M -38.9% | $5.4M +258.8% | -$3.4M | $1.3B | $1.1B | $990.2M |
| Net Change in Cash | $1.3B +290.1% | -$707.7M -160.5% | $1.2B +296.8% | $294.7M +188.6% | -$332.5M | $3.2B | $4.9B | $6.5B |
| Free Cash Flow | $2.5B +91.0% | $1.3B +73.9% | $749.6M -21.8% | $958.4M -44.8% | $1.7B | $8.6B | -$16.8B | $11.1B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Becton, Dickinson and Company
NYSE:BDX
$52.92B
ResMed Inc.
NYSE:RMD
$28.10B
West Pharmaceutical Services, Inc.
NYSE:WST
$23.26B
Hologic, Inc.
HOLX
$16.97B
The Cooper Companies, Inc.
NASDAQ:COO
$13.21B
Baxter International Inc.
NYSE:BAX
$10.68B
Repligen Corporation
NASDAQ:RGEN
$7.55B
Teleflex Incorporated
NYSE:TFX
$5.82B
Merit Medical Systems, Inc.
NASDAQ:MMSI
$3.97B
ICU Medical, Inc.
NASDAQ:ICUI
$3.59B
Embecta Corp.
EMBC
$185.20M
Stereotaxis, Inc.
STXS
$178.37M
NEXGEL, Inc.
NXGL
$5.34M
Bionano Genomics, Inc.
BNGO
$3.86M
Innovative Eyewear, Inc.
LUCY
$3.54M
SEC Filings
Recent regulatory filings
No filings found.
Does ISRG generate free cash flow?
Intuitive Surgical, Inc. (ISRG) generated $2.49B of free cash flow in fiscal 2025.
How much operating cash flow does ISRG produce?
Operating cash flow was $3.03B, before capital expenditures of $539.80M.
Explore More
Continue the stock analysis
Jump to another research area for this company.